The Czech Republic Annual Report 2010 Drug ... - Drogy-info.cz

More documents

Recommendations

Info

Figure 6-7: Proportion of injecting drug use among first-time treatment demands and all treatment demands related to heroin, Subutex ® , and pervitin use, in % (Studničková and Petrášová, 2011) Figure 6-8: Trends in the proportion of injecting heroin, pervitin, and polydrug users treated at outpatient psychiatric facilities, 1997– 2010, in % (Nechanská et al. 2011; Nechanská, 2011c) It seems that the proportion of injecting users demanding treatment who report sharing needles and syringes is declining in the long term; see Table 6-9. page 91
Table 6-9: Sharing of needles and syringes at any time in the past reported by IDUs demanding treatment in 2002–2010 (Studničková and Petrášová, 2011) Year Number of Number of IDUs sharing IDUs Sharing (%) 2002 6,437 2,590 40.2 2003 5,901 2,356 39.9 2004 6,314 2,725 43.2 2005 5,769 2,421 42.0 2006 5,860 2,313 39.5 2007 5,338 2,139 40.1 2008 5,766 2,057 35.7 2009 6,012 2,263 37.6 2010 6,581 2,146 32.6 A comparison of needs analyses of low-threshold programme clients in Prague from 2003 and 2010 also shows that there was a decline in the rate of risk behaviour (Šťastná, 2010); for more information see the chapter on Data on Problem Drug Use from Non-Treatment Sources (p. 52). The reported rate of lifetime and current (in the last month) needle sharing fell between these two years. In 2010, all clients except one exchanged used needles for new ones. 6.2 Other Drug-Related Health Correlates and Consequences 6.2.1 Non-Fatal Drug Intoxications The Public Health Office in Prague collects data about non-fatal intoxications 86 . There are still problems and major regional differences in the system of collecting data which make it complicated to evaluate trends 87 . In 2010 there were 849 cases of non-fatal intoxication with drugs; see Table 6-10. Table 6-10: Non-fatal drug intoxications in the Czech Republic, 2001–2009 (Studničková and Petrášová, 2011) Drug 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Pervitin 163 191 149 180 222 231 343 364 187 148 Heroin 285 176 152 179 244 149 190 166 122 162 Methadone 2 6 3 2 10 7 2 1 1 0 Subutex ® – – 2 12 14 18 32 7 0 0 Other opiates 16 23 22 20 19 21 40 17 42 24 Benzodiazepines 137 89 157 126 153 124 139 113 180 136 Other sedatives, hypnotics 195 137 82 103 88 107 125 135 127 112 Cannabis 63 101 90 84 73 72 127 108 105 102 Inhalants 75 58 69 64 48 28 31 9 33 18 Psilocybin 15 7 4 10 6 5 10 9 7 4 Cocaine, crack 4 2 6 5 7 8 1 7 2 0 Datura stramonium 4 0 0 0 1 0 1 5 2 0 LSD 3 2 3 7 3 5 7 4 13 3 MDMA 15 4 8 3 8 12 12 3 1 2 Other known drugs and pills 182 179 100 92 111 89 124 140 173 137 Other, unknown 24 25 34 65 186 78 71 58 23 1 Total 1,183 1,000 881 952 1,193 954 1,255 1,146 1,018 849 6.2.2 Psychiatric and Somatic Co-morbidity of Drug Users In addition to primary diagnoses, secondary diagnoses are also monitored for patients recorded in the National Register of Hospitalised Patients 88 . 86 This system reports cases of overdoses, as well as other health complications that require emergency hospitalisation. Various health facilities, primarily emergency units, provide reports to the system. 87 The trends in reported cases are also significantly influenced by changes in the network of reporting facilities (see the 2009 Annual Report). In 2010 there were still problems with reporting in Prague (five cases reported) and other regions (e.g. no cases were reported in the South Bohemia, Hradec Králové and South Moravia regions in 2010). 88 The primary diagnosis is defined as the primary condition that requires the patient to be hospitalised. The codes for other illnesses that complicate, i.e. impact on and justify the frequency, duration, volume and structure of the care provided and reported, are given as secondary diagnoses. As up to four secondary diagnoses are recorded, it must be noted that one hospitalisation record may be counted by the number of reported secondary diagnoses in up to four chapters of ICD-10. page 92
Page 1:
Annual Report The Czech Republic 20
Page 5 and 6:
Annual Report: The Czech Republic -
Page 7 and 8:
PART B: SELECTED ISSUES............
Page 9 and 10:
In 2010 the very first representati
Page 11 and 12:
In the Czech Republic, the treatmen
Page 13 and 14:
PART A: NEW DEVELOPMENTS AND TRENDS
Page 15 and 16:
ange applies to addictologists who
Page 17 and 18:
Republic has been reporting the hig
Page 19 and 20:
Wenceslas Square and in the surroun
Page 21 and 22:
Regions of the Czech Republic to ca
Page 23 and 24:
Region Pardubice Vysočina South Mo
Page 25 and 26:
educe drug supply (particularly to
Page 27 and 28:
Map 1-1: 2010 drug policy expenditu
Page 29 and 30:
Total state budget Regions Table 1-
Page 31 and 32:
1.3.2 Drug Treatment Costs Incurred
Page 33 and 34:
Table 1-9: Costs incurred by health
Page 35 and 36:
2 Drug Use in the General Populatio
Page 37 and 38:
Table 2-2: Prevalence rates of use
Page 39 and 40:
The M-CIDI questionnaire, containin
Page 41 and 42:
Table 2-6: Prevalence rates of use
Page 43 and 44:
Figure 2-2: Attitudes towards crimi
Page 45 and 46:
Table 2-7: Prevalence of use of can
Page 47 and 48: Table 2-8: 2010 Safer Party clients
Page 49 and 50: school curriculum and school rules;
Page 51 and 52: partly also by regional public heal
Page 53 and 54: 3.4 Indicated prevention Indicated
Page 55 and 56: 4 Problem Drug Use The EMCDDA defin
Page 57 and 58: Table 4-2: Prevalence estimates of
Page 59 and 60: Table 4-4: Prevalence estimates of
Page 61 and 62: The general population studies (see
Page 63 and 64: Information on treatment and counse
Page 65 and 66: 5.2.1 Professional Competency of Se
Page 67 and 68: Table 5-6: Number of outpatient hea
Page 69 and 70: Table 5-8: Number of healthcare fac
Page 71 and 72: The proportions found for prescribi
Page 73 and 74: Map 5-2: Sobering-up station networ
Page 75 and 76: Table 5-14: Network of inpatient fa
Page 77 and 78: care centres report to diagnostic i
Page 79 and 80: cannabis, especially among adolesce
Page 81 and 82: Map 5-4: Number of all treatment de
Page 83 and 84: Figure 5-8: Selected characteristic
Page 85 and 86: 5.3.3.2 Clients in Opiate Substitut
Page 87 and 88: Figure 5-10: Trends in the capacity
Page 89 and 90: Table 5-23: Number of hospitalisati
Page 91 and 92: Table 6-1: Number of newly detected
Page 93 and 94: Figure 6-5: Reported incidence of s
Page 95 and 96: The monitoring of testing for infec
Page 97: Table 6-8: Results of testing for H
Page 101 and 102: tests for cannabis; see Table 6-12.
Page 103 and 104: Pervitin was the cause of a fatal o
Page 105 and 106: Table 6-15: Deaths with the presenc
Page 107 and 108: Table 6-17: Fatal drug overdoses in
Page 109 and 110: Figure 6-13: Comparison of trends i
Page 111 and 112: 7 Responses to Health Correlates an
Page 113 and 114: Table 7-2: Selected services of low
Page 115 and 116: Map 7-2: Number of needles and syri
Page 117 and 118: Table 7-8: History of HBV, HCV, and
Page 119 and 120: 8 Social Correlates and Social Rein
Page 121 and 122: Altogether, 987 clients (610 of the
Page 123 and 124: 9 Drug-Related Crime, Prevention of
Page 125 and 126: Table 9-2: Number of persons arrest
Page 127 and 128: Figure 9-1: Total number of persons
Page 129 and 130: Table 9-7: Sentences and other meas
Page 131 and 132: Table 9-9: Drug-related misdemeanou
Page 133 and 134: in custody, and 8 being the inmates
Page 135 and 136: (approximately 0.5%). However, only
Page 137 and 138: Table 9-15: NGOs providing drug ser
Page 139 and 140: Supported by the National Focal Poi
Page 141 and 142: was rather bizarre. For example, th
Page 143 and 144: shut down by the authorities. The l
Page 145 and 146: the regional police headquarters on
Page 147 and 148: conduct research in the area of pen
Page 149 and 150:
Republic for the Period 2011-2012 f
Page 151 and 152:
departments) or by the external pro
Page 153 and 154:
more than 10 clients, etc. This is
Page 155 and 156:
12 Drug Users with Children The aim
Page 157 and 158:
Childbirth and the National Registe
Page 159 and 160:
Table 12-2: Total number of mothers
Page 161 and 162:
(diagnostic institutions), and reha
Page 163 and 164:
12.3.2 Helping Services Help to chi
Page 165 and 166:
13 Cross-border Travel, Drug Use, a
Page 167 and 168:
ethnic minorities in the Czech Repu
Page 169 and 170:
LIST OF TABLES Table 1-1: Overview
Page 171 and 172:
Table 9-10: Criminal offences commi
Page 173 and 174:
SELECTED DRUG-RELATED WEB PAGES ON
Page 175 and 176:
2005-2009 National Strategy - Natio
Page 177 and 178:
ministry, 18, 41, 42, 115 ministry
Page 179 and 180:
Generální ředitelství Vězeňsk
Page 181 and 182:
Mravčík, V., Zábranský, T., Kor
Page 183 and 184:
Policie ČR (2011) Statistické př
Page 185 and 186:
Van den Berg, C., Smit, C., Van Bru
show all

The Czech Republic Annual Report 2010 Drug ... - Drogy-info.cz

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?